awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28068643-18F2AAA6-1910-4F8E-B776-8F7EB76093EB
Q28068643-18F2AAA6-1910-4F8E-B776-8F7EB76093EB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28068643-18F2AAA6-1910-4F8E-B776-8F7EB76093EB
Focus on Alectinib and Competitor Compounds for Second-Line Therapy in ALK-Rearranged NSCLC
P2860
Q28068643-18F2AAA6-1910-4F8E-B776-8F7EB76093EB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28068643-18F2AAA6-1910-4F8E-B776-8F7EB76093EB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
80b7c555db4cb0e6338c384874ee21f7d44653cd
P2860
Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancer